Tuesday, June 16, 2026

Dynasty Branding on Display at Pyongyang Mega Project

North Korea has completed 50,000 housing units in Pyongyang, showcasing Kim Jong Un's family and signaling regime stability.

SK Hynix Surpasses Samsung to Lead Global Memory Market for First Time

SK Hynix surpasses Samsung in global memory sales for Q2, with a significant rise in HBM market share amid Samsung's struggles.

Talk Show Host’s Racist Joke to BTS Sparks Outrage

A talk show host faces backlash for a racially insensitive joke about BTS during a recording, leading to apologies and criticism.

Tag: Lirafugratinib

HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review

HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.

HLB Group Unveils Groundbreaking Cancer Treatments at AACR 2026: What You Need to Know

HLB Group will present key findings on anti-cancer therapies at AACR 2026, highlighting SynKIR-110 and Lirafugratinib's advancements.

Top News

- Our Sponsors Ad -

Follow us